David Wishart’s The Metabolomics Innovation Centre helped determine how COVID-19 affects different metabolites in an effort to build new tests and possibly create secondary therapeutics. (Photo: John Ulan)

Study identifies biomarkers that could be used in a quick, inexpensive COVID-19 blood screening tool

Posted on

How COVID-19 affects concentration of certain metabolites could also pinpoint who is most at-risk of death and even lead to a secondary therapy that could improve disease outcomes.

The concentration of specific metabolites in the blood could act as the foundation for a quick, inexpensive blood test that detects not only the presence of COVID-19 but which patients are at risk of becoming critically ill, according to a pan-Canadian study that included researchers from the University of Alberta….

https://www.folio.ca/study-identifies-biomarkers-that-could-be-used-in-a-quick-inexpensive-covid-19-blood-screening-tool/

Read More Impact Stories

Posted on
A comprehensive study by scientists at UdeM maps the evolutionary dynamics and risks of viral emergence of diseases that could [...]
Posted on
This article is available only in French. Infections respiratoires: mieux trier les patients pour soulager la pression sur les urgences [...]
Posted on
UBC’s Dr. James Lim is part of a research team helping to bring new hope to children battling hard-to-treat cancers. [...]